Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II study of ASC-40 for the treatment of acne vulgaris approved in China

Aug. 9, 2021

Proteins found to promote neuroinflammation in MS

Aug. 9, 2021

Bentrio shows prophylactic and therapeutic effects against influenza A

Aug. 9, 2021

Initial results presented from first-in-human study of ABNCoV2 vaccine

Aug. 9, 2021

AIkido to use machine learning in development of novel broad-spectrum antivirals

Aug. 9, 2021

Targeting synaptogyrin-3 can ameliorate cognitive deficits

Aug. 9, 2021

Ichnos nominates ISB-1442 as its next clinical candidate

Aug. 9, 2021

ImmVira receives NMPA approval for clinical testing of intravenous MVR-T3011

Aug. 9, 2021

New SHP-2 inhibitors identified at Beijing Innocare Pharmaceutical Technology

Aug. 9, 2021

Dongguan Hec New Drug Research and Development, Sunshine Lake Pharma identify HBV inhibitors

Aug. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...